(Q62607246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Mariagrazia Rumi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Alessio Aghemo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Anna L. Fracanzani

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Raffaela Rametta

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Enrico Galmozzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Benedetta Del Menico

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Stella De Nicola

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Paola Dongiovanni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Marco Maggioni

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Massimo Colombo

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Silvia Fargion

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

English

0 references

publication date

11 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

791-799

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

Prognosis of chronic hepatitis C: results of a large, prospective cohort study.

22 January 2020

cites work

1 reference

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

7 January 2021

Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors

1 reference

7 January 2021

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

7 January 2021

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

7 January 2021

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

1 reference

7 January 2021

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

1 reference

7 January 2021

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

1 reference

7 January 2021

Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus

1 reference

7 January 2021

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

7 January 2021

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

7 January 2021

Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.

1 reference

7 January 2021

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

1 reference

7 January 2021

TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis.

1 reference

7 January 2021

Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis

1 reference

7 January 2021

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

1 reference

7 January 2021

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

1 reference

7 January 2021

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

1 reference

7 January 2021

I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

1 reference

7 January 2021

A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans

1 reference

7 January 2021

A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis

1 reference

7 January 2021

HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Management of hepatocellular carcinoma

1 reference

7 January 2021

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

1 reference

7 January 2021

A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents

1 reference

7 January 2021

Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene

1 reference

7 January 2021

Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent

1 reference

7 January 2021

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

1 reference

7 January 2021

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

1 reference

7 January 2021

Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.

1 reference

7 January 2021

Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis

1 reference

7 January 2021

Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis

1 reference

7 January 2021

Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C

1 reference

7 January 2021

Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.24123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21319195%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference